Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BYHaematologica

Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma

3 more authors
5 affiliations
  1. 1Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
  2. 2Department of Pharmacy, Cedars Sinai Medical Center, Los Angeles, CA 90048
  3. 3Department of Pharmacy, City of Hope, Duarte, CA 91010
  4. 4Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048; Regenerative Medicine Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, CA 90048
  5. 5Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048

Related

  1. ASSOCIATION BETWEEN INTERFERON-Γ LEVELS IN MOBILIZED HEMATOPOIETIC STEM CELL PRODUCTS AND LOSS OF RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
    Laura Gabriela CARDOSO, Letícia NAVARRO GORDAN FERREIRA MARTINS, Ana Luiza GOULART STARCK +4
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  2. SERUM IL-12 PREDICTS MINIMAL RESIDUAL DISEASE NEGATIVITY AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Alexandra Fernandes CALLERA, Evandro Secchi ROSA, Fernando CALLERA
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  3. Efficacy and safety of air-flow beds for autologous hematopoietic stem cell transplantation in multiple myeloma: a retrospective cohort study
    Zhangbiao Long, Dinghui Zhao, Min Ruan +8
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Healthcare resource utilisation and costs of chemotherapy and autologous haemopoietic cell transplantation of patients with multiple myeloma in China: a multi-centre retrospective analysis
    Yannan Wang, Ling Li, Peng Ji +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  5. Prognostic Impact of EASIX According to the Timing of Assessment in Newly Diagnosed Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Diana Fortoeș, Ion Antohe, Vlad-Andrei Cianga +10
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{lee2026realworld,
  title = {{Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma}},
  author = {Hannah Lee and Ronald L. Paquette and Haein Kim and Brittany McGalliard and Eyman Sonbol and David R. Oveisi and Noah M. Merin and Joshua Sasine and Akil Merchant and Justin Darrah and Fatima Khan and Christopher Lopiccolo and John P. Chute and Oksana Volod and Robert Vescio},
  journal = {Haematologica},
  year = {2026},
  month = oct,
  doi = {10.3324/haematol.2026.301181},
  url = {https://doi.org/10.3324/haematol.2026.301181},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma
AU  - Hannah Lee
AU  - Ronald L. Paquette
AU  - Haein Kim
AU  - Brittany McGalliard
AU  - Eyman Sonbol
AU  - David R. Oveisi
AU  - Noah M. Merin
AU  - Joshua Sasine
AU  - Akil Merchant
AU  - Justin Darrah
AU  - Fatima Khan
AU  - Christopher Lopiccolo
AU  - John P. Chute
AU  - Oksana Volod
AU  - Robert Vescio
PY  - 2026
DA  - 2026/10/29
JO  - Haematologica
DO  - 10.3324/haematol.2026.301181
UR  - https://doi.org/10.3324/haematol.2026.301181
SN  - 0390-6078
SN  - 1592-8721
ER  -